Roche empowers patients and improves HCP communication with Temedica’s indication-specific Digital Patient Companion

The omnichannel marketing approach stands as a cornerstone in the strategy of every forward-thinking pharmaceutical company. In order to capture HCP & patient attention and establish a lasting brand presence, messages should be precisely tailored for the specific audience, distributed through suitable channels, timed appropriately, and presented in an optimal format throughout the customer journey. While the concept is well-defined, the real challenge is turning it into reality.
Our experts Dr. Patrick Markt-Niederreiter, VP Digital Excellence, Daiichi Sankyo Europe and Gloria Seibert, CEO, Temedica discussed this insightful topic in a 60-minute webinar.
The webinar is held in German.
The experts covered:
and many more
Temedica GmbH